Constructive Bio, a trailblazer in synthetic genomics, has secured a remarkable $58 million in Series A funding, spearheading advances in biofactory technology.Established recently as a University…
Cambridge-based Constructive Bio has raised £43.4m in its Series A funding round.Founded in 2021, the company focuses on developing programmable molecules.The funding was led by Ahren,…
